Zealand Pharma A/S

(NASDAQ:ZEAL) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Zealand Pharma A/S is a biotechnology company. It is focused on the discovery, design, and development of peptide-based medicines. Its products include soliqua 100/33/suliqua and adlyxin. The firm focuses on gastrointestinal diseases and metabolic diseases. Its product pipeline includes dasiglucagon, glepaglutide, and dual glucagon product candidates.

Contact Information

Website: www.zealandpharma.com
Email: info@zealandpharma.com
Main Phone: +45 88773600
Address: Sydmarken 11
Address 2: Glostrup
City / Town: Soborg
Country: DK
Postal Code: DK-2860

Issuer Information

Exchange: NGS
CEO: Emmanuel Dulac
Employees: 626

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A